These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 7505277)
21. The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation. Fan H; Villegas C; Huang A; Wright JA Cancer Res; 1998 Apr; 58(8):1650-3. PubMed ID: 9563477 [TBL] [Abstract][Full Text] [Related]
22. Cyclic AMP mediated GSTP1 gene activation in tumor cells involves the interaction of activated CREB-1 with the GSTP1 CRE: a novel mechanism of cellular GSTP1 gene regulation. Lo HW; Ali-Osman F J Cell Biochem; 2002; 87(1):103-16. PubMed ID: 12210727 [TBL] [Abstract][Full Text] [Related]
23. Regulation of C/EBPbeta mRNA expression and C/EBPbeta promoter activity by protein kinases A and C in a myelomonocytic cell line (HD11). Goethe R; Basler T; Phi-van L Inflamm Res; 2007 Jul; 56(7):274-81. PubMed ID: 17659432 [TBL] [Abstract][Full Text] [Related]
24. SCH 51344 inhibits ras transformation by a novel mechanism. Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559 [TBL] [Abstract][Full Text] [Related]
25. Expression of ribonucleotide reductase after ionizing radiation in human cervical carcinoma cells. Kuo ML; Kinsella TJ Cancer Res; 1998 May; 58(10):2245-52. PubMed ID: 9605773 [TBL] [Abstract][Full Text] [Related]
26. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Su ZZ; Austin VN; Zimmer SG; Fisher PB Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744 [TBL] [Abstract][Full Text] [Related]
27. The transmembrane domain of the large subunit of HSV-2 ribonucleotide reductase (ICP10) is required for protein kinase activity and transformation-related signaling pathways that result in ras activation. Smith CC; Luo JH; Hunter JC; Ordonez JV; Aurelian L Virology; 1994 May; 200(2):598-612. PubMed ID: 8178446 [TBL] [Abstract][Full Text] [Related]
28. Deregulated expression and function of CFTR and Cl- secretion after activation of the Ras and Src/PyMT pathways in Caco-2 cells. Davenport SE; Mergey M; Cherqui G; Boucher RC; Gespach C; Gabriel SE Biochem Biophys Res Commun; 1996 Dec; 229(2):663-72. PubMed ID: 8954955 [TBL] [Abstract][Full Text] [Related]
29. cAMP-independent signaling regulates steroidogenesis in mouse Leydig cells in the absence of StAR phosphorylation. Manna PR; Chandrala SP; Jo Y; Stocco DM J Mol Endocrinol; 2006 Aug; 37(1):81-95. PubMed ID: 16901926 [TBL] [Abstract][Full Text] [Related]
30. Transcriptional regulation of secretogranin II and chromogranin B by cyclic AMP in a rat pheochromocytoma cell line. Thompson ME; Valentine DL; Strada SJ; Wagner JA; Scammell JG Mol Pharmacol; 1994 Nov; 46(5):880-9. PubMed ID: 7969075 [TBL] [Abstract][Full Text] [Related]
31. cAMP-mediated signals as determinants for apoptosis in primary granulosa cells. Aharoni D; Dantes A; Oren M; Amsterdam A Exp Cell Res; 1995 May; 218(1):271-82. PubMed ID: 7537693 [TBL] [Abstract][Full Text] [Related]
32. The cell biology of ras-induced transformation: insights from studies utilizing an inducible hybrid oncogene system. Haliotis T; Trimble W; Chow S; Mills G; Girard P; Kuo JF; Govindji N; Hozumi N Anticancer Res; 1988; 8(5A):935-45. PubMed ID: 2845854 [TBL] [Abstract][Full Text] [Related]
33. Regulation of the preprotachykinin-I gene promoter through a protein kinase A-dependent, cyclic AMP response element-binding protein-independent mechanism. Calin-Jageman IE; Wang J; Bannon MJ J Neurochem; 2006 Apr; 97(1):255-64. PubMed ID: 16515544 [TBL] [Abstract][Full Text] [Related]
34. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability. Huang A; Fan H; Taylor WR; Wright JA Cancer Res; 1997 Nov; 57(21):4876-81. PubMed ID: 9354452 [TBL] [Abstract][Full Text] [Related]
35. Cell cycle regulation of ribonucleoside diphosphate reductase activity in permeable mouse L cells and in extracts. Kucera R; Brown CL; Paulus H J Cell Physiol; 1983 Nov; 117(2):158-68. PubMed ID: 6355126 [TBL] [Abstract][Full Text] [Related]
36. Posttranscriptional regulation of ribonucleotide reductase R1 gene expression is linked to a protein kinase C pathway in mammalian cells. Chen FY; Amara FM; Wright JA Biochem Cell Biol; 1994; 72(7-8):251-6. PubMed ID: 7893463 [TBL] [Abstract][Full Text] [Related]
37. Mammalian cell lines engineered to identify inhibitors of specific signal transduction pathways. Jones RE; Defeo-Jones D; McAvoy EM; Vuocolo GA; Wegrzyn RJ; Haskell KM; Oliff A Oncogene; 1991 May; 6(5):745-51. PubMed ID: 1711189 [TBL] [Abstract][Full Text] [Related]
38. Regulation of mammalian ribonucleotide reductase R1 mRNA stability is mediated by a ribonucleotide reductase R1 mRNA 3'-untranslated region cis-trans interaction through a protein kinase C-controlled pathway. Chen FY; Amara FM; Wright JA Biochem J; 1994 Aug; 302 ( Pt 1)(Pt 1):125-32. PubMed ID: 8067998 [TBL] [Abstract][Full Text] [Related]
39. Influence of cell type on the steroidogenic potential and basal cyclic AMP levels of ras-oncogene-transformed rat cells. Pan J; Roskelley CD; Auersperg N Differentiation; 1995 Jun; 58(5):321-8. PubMed ID: 7622009 [TBL] [Abstract][Full Text] [Related]
40. Alterations in the activity and regulation of mammalian ribonucleotide reductase by chlorambucil, a DNA damaging agent. Hurta RA; Wright JA J Biol Chem; 1992 Apr; 267(10):7066-71. PubMed ID: 1551913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]